Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression

NCT05383313 is registered in ClinicalTrials.gov with National Institute of Mental Health, Czech Republic as lead sponsor.

NCT NCT05383313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05383313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression
Lead sponsor
National Institute of Mental Health, Czech Republic
Phase
Phase 2
Overall status
Unknown status
Start date
May 1, 2021
Completion date
April 30, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression